AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
AntiCan↑, TumCCA↑, Apoptosis↑, eff↑, Bcl-2↓, survivin↓, P21↑, p27↑, BAX↑, Cyt‑c↑, Casp3↑, PI3K↓, Akt↓, mTOR↓, Hif1a↓, PTEN↑, AMPKα↑, PDH↑, LDHA↓, antiOx↓, ROS↑, AntiCan↑,
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
GL26 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
CRC, |
RKO |
|
|
|
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2780S |
|
|
|
Bacteria↓, antiOx↑, AntiCan↑, eff↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
NRF2↑, TumCCA↑, ROS↑, selectivity↑, *AntiViral↑, *toxicity↝, ETC↓, MMP↓, DNAdam↑, Apoptosis↑, lipid-P↑, other↝, UPR↑, *GRP78/BiP↑, *p‑PERK↑, *cl‑eIF2α↑, *CHOP↑, *JNK↑, Hif1a↓, AntiCan↑, *toxicity↓, eff↑,
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, Endoglin↑, Casp3↑, Casp8↑, Casp9↑, ATG5↑, Beclin-1↑, p62↑, PARP↑,
TumCG↓, MAPK↓, TumCCA↑, Apoptosis↑, ROS↑, DNAdam↑, AntiCan↑,
GutMicro↑, HCAR2↑, AntiCan↑, Inflam↓, IL18↑,
AntiCan↑, GutMicro↝,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
- |
in-vivo, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, eff↑, TumCP↓, TumCCA↓, cycD1/CCND1↓, Pyro↑, Apoptosis↑, cl‑GSDME↑, Bcl-2↓, Cyt‑c↑, Casp9↑, TumCG↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, Apoptosis↑, selectivity↑, Ca+2↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vivo, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, selectivity↑, TumCCA↑, P21↑, Apoptosis↑,
TumCI↓, TumCMig↓, EMT↓, Smad1↓, AntiCan↑, Snail↓, Slug↓, Zeb1↓, ZEB2↓, TGF-β1↓, eff↑, E-cadherin↑, N-cadherin↓, Vim↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
DLD1 |
|
|
|
β-catenin/ZEB1↓, Wnt↓, TumCP↓, TumCMig↓, *antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *Bacteria↓, *memory↑, AntiCan↑, NF-kB↓, cFos↓, ATF2↓, CREB↓,
Inflam↓, AntiCan↑, Apoptosis↑, MMP↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, NF-kB↓, IL6↓, IL1β↓, *antiOx↑, *lipid-P↓, *ROS↓, MAPK↓, JAK↓, STAT↓, PI3K↓, Akt↓, chemoP↑, ROS⇅, DNAdam↑, ChemoSen↝,
AntiCan↑, selenoP↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
AntiCan↑, NRF2↓, Prx↓, ChemoSen↑, *Prx↑, *NRF2↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
Dose↝, AntiCan↑, eff↑,
Risk↓, Risk↓, Dose∅, AntiCan↑,
| - |
in-vitro, |
Cerv, |
INT-407 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, CTNNB1↓, Twist↓, Bcl-2↓, survivin↓, NF-kB↓, Sp1/3/4↓, BAX↑, P21↑, P53↑, eff↓, TumCMig↓,
Showing Research Papers: 1 to 19 of 19
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 19
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 1, lipid-P↑, 1, NRF2↓, 1, NRF2↑, 1, Prx↓, 1, ROS↑, 6, ROS⇅, 1, selenoP↓, 1,
Mitochondria & Bioenergetics ⓘ
ETC↓, 1, MMP↓, 2,
Core Metabolism/Glycolysis ⓘ
CREB↓, 1, LDHA↓, 1, PDH↑, 1,
Cell Death ⓘ
Akt↓, 2, Apoptosis↑, 10, ATF2↓, 1, BAX↑, 3, Bcl-2↓, 5, Casp↑, 1, Casp3↑, 4, Casp8↑, 2, Casp9↑, 4, Cyt‑c↑, 3, cl‑GSDME↑, 1, MAPK↓, 2, p27↑, 1, Pyro↑, 1, survivin↓, 2,
Kinase & Signal Transduction ⓘ
AMPKα↑, 1, HCAR2↑, 1, Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
UPR↑, 1,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, Beclin-1↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 4, P53↑, 2, PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 3, TumCCA↓, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
cFos↓, 1, CTNNB1↓, 1, EMT↓, 1, mTOR↓, 1, PI3K↓, 2, PTEN↑, 1, STAT↓, 1, TumCG↓, 4, Wnt↓, 1,
Migration ⓘ
Ca+2↑, 1, E-cadherin↑, 1, N-cadherin↓, 1, Slug↓, 1, Smad1↓, 1, Snail↓, 1, TGF-β1↓, 1, TumCI↓, 1, TumCMig↓, 4, TumCP↓, 2, Twist↓, 1, Vim↓, 1, Zeb1↓, 1, ZEB2↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
Endoglin↑, 1, EPR↑, 1, Hif1a↓, 2,
Immune & Inflammatory Signaling ⓘ
HCAR2↑, 1, IL18↑, 1, IL1β↓, 1, IL6↓, 1, Inflam↓, 2, JAK↓, 1, NF-kB↓, 3,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, ChemoSen↝, 1, Dose↝, 1, Dose∅, 1, eff↓, 1, eff↑, 8, selectivity↑, 4,
Clinical Biomarkers ⓘ
GutMicro↑, 1, GutMicro↝, 1, IL6↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 20, chemoP↑, 1, Risk↓, 2,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 93
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, lipid-P↓, 1, NRF2↑, 1, Prx↑, 1, ROS↓, 1,
Cell Death ⓘ
JNK↑, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, cl‑eIF2α↑, 1, GRP78/BiP↑, 1, p‑PERK↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Functional Outcomes ⓘ
hepatoP↑, 1, memory↑, 1, neuroP↑, 1, toxicity↓, 1, toxicity↝, 1,
Infection & Microbiome ⓘ
AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 18
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page